Bellerophon Therapeutics, Inc.·4

Jun 14, 4:37 PM ET

Fernandes Peter 4

4 · Bellerophon Therapeutics, Inc. · Filed Jun 14, 2018

Insider Transaction Report

Form 4
Period: 2018-06-12
Fernandes Peter
Chief Regulatory Officer
Transactions
  • Tax Payment

    Common Stock

    2018-06-12$2.37/sh11,304$26,790102,676 total

Documents

1 file
  • 4
    wf-form4_152900861084942.xmlPrimary

    FORM 4